Skip to content

Prospective Measurement of Normal Venous Sinus Pressures

Venous Sinus Pressures in Normal Individuals

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03948971
Enrollment
10
Registered
2019-05-14
Start date
2020-01-13
Completion date
2027-05-01
Last updated
2026-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Venous Pressures

Keywords

cerebral arteriography

Brief summary

The purpose of this research is to document normal intracranial venous sinus pressures. Participants who need to have a cerebral angiogram to evaluate a medical problem not related to Idiopathic Intracranial Hypertension (IIH) will be invited to participate. Participation in this research will not require any extra visits. The intervention will take place in the interventional radiology suite when the subject has an angiogram. IIH is a condition that causes increased pressure in the brain in the absence of a tumor or other diseases that may be causing symptoms. Symptoms include headaches and visual disturbances not explained by other things. In IIH there is a narrowing in the sinuses of the brain that causes the increased pressure.

Detailed description

Patients will be prospectively enrolled into the study. All adult patients, aged of 18-60, determined to be candidates for elective cerebral arteriography will be screened for inclusion in this study. Patients consenting to participate and enrolled in the study will first undergo their standard cerebral angiogram procedure, as clinically indicated. Once the procedure is completed, enrolled subjects will then undergo the study intervention. 1. Insertion of an additional catheter in the femoral vein. 2. Navigation of the catheter into the internal jugular bulb and then catheter navigation into the superior sagittal sinus will result in additional fluoroscopic time (requires \ 60 seconds of additional fluoroscopy time; carries a minimum risk of vessel perforation or other untoward event \[incidence of complication associated with this procedure in the PI patient series is 0%\]). There is additionally some ear pain that can happen with this Venogram. 3. 5-10 minutes of additional procedure time. Much of this time period is merely a waiting period while the pressures stabilize and are recorded. 4. An additional venogram injection through the catheter which exposes subjects to an additional 1-2 ml of contrast dye and 3-4 seconds of additional fluoroscopy time and its associated radiation dose.

Interventions

PROCEDUREVenogram

The 5 French (5F) diagnostic catheter will be navigated into the inferior then superior vena cava and then into the internal jugular bulb on the dominant venous side (as determined from the arteriographic images). Next, a 0.027 inch microcatheter will be navigated using fluoroscopic guidance into the superior sagittal sinus and a venogram will then performed by injecting a small dose of contrast. Next, the venous sinus pressure waveforms will be recorded as the catheter is withdrawn into the jugular bulb and then in the superior vena cava to obtain a central venous pressure. Once completed, the catheters will be removed and the sheaths will be removed. Manual pressure will be held at the venous access site for a few minutes. The arterial sheath will be closed based upon standard arteriogram protocol.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Adult patients aged 18-60 years determined to be candidates for elective cerebral arteriography will be screened for inclusion in this study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Candidates for elective cerebral arteriography

Exclusion criteria

* All patients with active, or a history of, intracranial venous pathology (arteriovenous malformation, arteriovenous fistulae, idiopathic intracranial hypertension, venous sinus thrombosis). * Patients with severe daily headaches or symptoms of idiopathic intracranial hypertension will also be excluded. * Body mass index \> 35. * Known diagnosis of heart failure or pulmonary hypertension. * Pregnant women will be excluded due to the radiation risk associated with Angiogram and Venogram.

Design outcomes

Primary

MeasureTime frameDescription
Superior Sagittal Sinus Pressureduring venogram, up to 10 minutesSuperior sagittal sinus pressure will be recorded in mmHg as the catheter is withdrawn into the jugular bulb.
Torcula Sinus Pressureduring venogram, up to 10 minutesTorcula sinus pressure will be recorded in mmHg as the catheter is withdrawn into the jugular bulb.
Dominant Transverse Sinusduring venogram, up to 10 minutesDominant transverse sinus will be recorded in mmHg as the catheter is withdrawn into the jugular bulb.
Dominant Transverse-Sigmoid Sinus Junctionduring venogram, up to 10 minutesdominant transverse-sigmoid sinus junction will be recorded in mmHg as the catheter is withdrawn into the jugular bulb.
Dominant Sigmoid Sinusduring venogram, up to 10 minutesDominant sigmoid sinus will be recorded in mmHg as the catheter is withdrawn into the jugular bulb.
Dominant Internal Jugular Veinduring venogram, up to 10 minutesDominant internal jugular vein will be recorded in mmHg as the catheter is withdrawn into the jugular bulb.
Central Venous Pressuresduring venogram, up to 10 minutesCentral venous pressures will be recorded in mmHg as the catheter is withdrawn into the jugular bulb.

Countries

United States

Contacts

CONTACTKimberly Hawley
kimberly.hawley@advocatehealth.org336-716-4031
CONTACTKyle Fargen, MD
kyle.fargen@advocatehealth.org
PRINCIPAL_INVESTIGATORKyle Fargen, MD

Wake Forest University Health Sciences

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 27, 2026